CME Group Inc. (NASDAQ:CME) Shares Sold by Stonegate Investment Group LLC

Stonegate Investment Group LLC lessened its stake in CME Group Inc. (NASDAQ:CMEFree Report) by 17.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,429 shares of the financial services provider’s stock after selling 297 shares during the quarter. Stonegate Investment Group LLC’s holdings in CME Group were worth $301,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in CME. Norges Bank acquired a new stake in shares of CME Group in the fourth quarter valued at approximately $610,482,000. Morgan Stanley boosted its position in shares of CME Group by 31.5% during the third quarter. Morgan Stanley now owns 4,858,967 shares of the financial services provider’s stock worth $972,863,000 after buying an additional 1,163,103 shares during the period. PineStone Asset Management Inc. boosted its position in shares of CME Group by 261.4% during the third quarter. PineStone Asset Management Inc. now owns 1,280,194 shares of the financial services provider’s stock worth $256,320,000 after buying an additional 925,939 shares during the period. Barclays PLC boosted its position in shares of CME Group by 90.0% during the second quarter. Barclays PLC now owns 1,218,481 shares of the financial services provider’s stock worth $225,771,000 after buying an additional 577,293 shares during the period. Finally, 1832 Asset Management L.P. boosted its position in shares of CME Group by 992.8% during the first quarter. 1832 Asset Management L.P. now owns 623,999 shares of the financial services provider’s stock worth $119,508,000 after buying an additional 566,899 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

CME has been the subject of a number of recent research reports. The Goldman Sachs Group lowered CME Group from a “neutral” rating to a “sell” rating and set a $195.00 target price for the company. in a report on Wednesday, January 3rd. Barclays lifted their target price on CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a report on Thursday, February 15th. Rosenblatt Securities reiterated a “sell” rating and issued a $180.00 target price on shares of CME Group in a report on Thursday, January 4th. Argus lifted their target price on CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a report on Wednesday, March 6th. Finally, Keefe, Bruyette & Woods reiterated a “market perform” rating and issued a $229.00 target price on shares of CME Group in a report on Wednesday. Two analysts have rated the stock with a sell rating, six have issued a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $218.36.

Read Our Latest Research Report on CME Group

CME Group Stock Down 1.3 %

CME Group stock opened at $212.03 on Thursday. The stock’s fifty day moving average is $213.21 and its two-hundred day moving average is $211.10. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 1-year low of $175.73 and a 1-year high of $223.80. The stock has a market cap of $76.33 billion, a PE ratio of 23.90, a P/E/G ratio of 3.35 and a beta of 0.49.

CME Group (NASDAQ:CMEGet Free Report) last posted its earnings results on Wednesday, February 14th. The financial services provider reported $2.37 EPS for the quarter, topping analysts’ consensus estimates of $2.27 by $0.10. The business had revenue of $1.44 billion for the quarter, compared to analysts’ expectations of $1.43 billion. CME Group had a return on equity of 12.32% and a net margin of 57.83%. The business’s revenue was up 19.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.92 earnings per share. On average, sell-side analysts expect that CME Group Inc. will post 9.61 EPS for the current fiscal year.

CME Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 26th. Shareholders of record on Friday, March 8th were issued a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a yield of 2.17%. The ex-dividend date of this dividend was Thursday, March 7th. This is a positive change from CME Group’s previous quarterly dividend of $1.10. CME Group’s payout ratio is currently 51.86%.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.